Back to ELVN
ORBIMED ADVISORS LLC ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$310.6M
Q3 2026
Peak value
$343.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $122.6M |
| Q1 2026 | $312M |
| Q2 2026 | $343.9M |
| Q3 2026 | $310.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $310.6M | 6.78M | — | — |
| Q2 2026 | $343.9M | 6.78M | — | — |
| Q1 2026 | $312M | 7.96M | — | — |
| Q4 2025 | $122.6M | 7.96M | — | — |
Other funds holding ELVN
$449.6M
$394.2M
$326.4M
$294.5M
$261.1M
$198.6M
$166.2M